Q2 2026 Ginkgo Bioworks Holdings Inc Earnings Call Transcript
I'm Daniel Marshall, Senior Manager of Communications and ownership. I'm joined by Jason Kelly, our Co-Founder and CEO; and Steve Cohen, our CFO. Thanks, as always, for joining us. We're looking forward to updating you on our progress.
As a reminder, during the presentation today, we will be making forward-looking statements, which involve risks and uncertainties. Please refer to our filings with the SEC to learn more about these risks and uncertainties, including our most recent 10-K.
Today, in addition to updating you on the quarter results, we're going to make the argument that autonomous labs are an imperative for American Science. We're also going to provide insight into how we are going to scale the capabilities of Nebula, our autonomous lab in Boston, and share an update on how we are getting autonomous labs like enhance the next generation of scientists. As usual, we'll end with the Q&A session, and I'll take questions from analysts, investors, and the public can submit those
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
